Ridge Preservation With Moldable Beta-tricalcium Phosphate Bone Substitute on Non-containable Non-Molar Extraction Sites



Status:Recruiting
Conditions:Dental
Therapuetic Areas:Dental / Maxillofacial Surgery
Healthy:No
Age Range:18 - Any
Updated:9/7/2018
Start Date:August 1, 2017
End Date:October 2019
Contact:Yusuke Hamada, DDS
Email:yuhamada@iupui.edu
Phone:317-274-5121

Use our guide to learn which trials are right for you!

Ridge Preservation With Hardening Calcium Phosphate Bone Substitutes and Resorbable Membrane for Implant Site Development on Non-containable Extraction Sites: A Clinical and Histological Prospective Case Series in Humans

Purpose of the single arm study is to clinically and histologically evaluate alloplastic
in-situ hardening, moldable beta-tricalcium phosphate(TCP) bone graft material and
polylactide membrane in alveolar ridge preservation following extraction of non-molar teeth
with non-containable extraction sockets.


Inclusion Criteria:

- adequate restorative space for a dental implant restoration, if the subject decides
previous to study participation that they would like an implant. Note, agreement to
implant placement is not a requirement of the study

- minimum of 10-mm vertical bone without impinging on adjacent vital structures
(Maxillary sinus, neurovascular bundles)

- single-rooted tooth to be extracted

- American Society of Anesthesiologists (ASA) Physical Status Classification I or II

- age >18 years old

- subjects who had >50% of height on any portion on the buccal wall of dehiscence and/or
fenestration of the extraction socket following extraction will be included from this
study

- adjacent teeth to extraction site will be present during healing period

- willingly sign informed consent and authorization.

Exclusion Criteria:

- do not meet any inclusion criteria

- pregnancy or nursing woman

- subjects with active systemic or localized infection (exclude chronic periodontitis)

- subjects with a history of any medical conditions that contraindicated or weighed
against dental implant placement such as history of bisphosphonate drug use,
chemotherapeutic or immunosuppressive agents, autoimmune disease, or poorly controlled
diabetes (HBA1c>7%)

- subjects with smoking habit (more than 10 cigarettes per day)
We found this trial at
1
site
Indianapolis, Indiana 46202
Phone: 317-274-5121
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials